Abstract
The intravenous administration of 5.0 mg of glucagon to 16 digitalized patients on the first postoperative day after prosthetic valve replacement resulted in significant cardiac inotropic effects. Since glucagon is effective in the presence of catecholamine depletion or beta-adrenergic blockade and appears to have little arrhythmogenic potential, it would appear to be a useful agent for the treatment of myocardial depression occurring in association with open cardiac surgery.
Sign-in/Register to access full text options 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
